Related Experiment Video

Updated: Apr 28, 2026

Combining Behavior and EEG to Study the Effects of Mindfulness Meditation on Episodic Memory
08:16

Combining Behavior and EEG to Study the Effects of Mindfulness Meditation on Episodic Memory

Published on: May 11, 2020

8.8K

[Effects of a neuropsychology program based on mindfulness on Alzheimer's disease: randomized double-blind clinical

Domingo Jesús Quintana Hernández1, María Teresa Miró Barrachina2, Ignacio Ibáñez Fernández2

  • 1Asociación Canaria para el desarrollo de la salud a través de la atención, Las Palmas de Gran Canaria, España; CSS El Pino, Grupo Sanitario ICOT, Las Palmas de Gran Canaria, España.

Revista Espanola De Geriatria Y Gerontologia
|June 2, 2014
PubMed
Abstract

Keywords:
Alzheimer's diseaseAtención plena o mindfulnessCogniciónCognitionEnfermedad de AlzheimerFuncionalidadFunctionalityMindfulnessPsicopatologíaPsychopathology

More Related Videos

Mindfulness in Motion MIM: An Onsite Mindfulness Based Intervention MBI for Chronically High Stress Work Environments to Increase Resiliency and Work Engagement12:22

Mindfulness in Motion MIM: An Onsite Mindfulness Based Intervention MBI for Chronically High Stress Work Environments to Increase Resiliency and Work Engagement

Published on: July 1, 2015

26.3K
Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment07:01

Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment

Published on: September 20, 2020

3.9K

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
20
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
32